HARVARD BIOSCIENCE, INC. (NASDAQ:HBIO) Files An 8-K Results of Operations and Financial Condition

HARVARD BIOSCIENCE, INC. (NASDAQ:HBIO) Files An 8-K Results of Operations and Financial Condition

Story continues below

Item 2.02. Results of Operations and Financial Condition.

On April 27, 2017, Harvard Bioscience, Inc. issued a press
release announcing financial results for the three months ended
March 31, 2017 and the details of a related conference call to be
held at 4:30 PM EST on April 27, 2017. The press release is
furnished as Exhibit 99.1 and incorporated herein by reference.

The information in Item 2.02 of this Current Report on Form 8-K
and Exhibit 99.1 attached hereto shall not be deemed filed for
purposes of Section 18 of the Securities Exchange Act of 1934
(the Exchange Act) or otherwise subject to the liabilities of
that section, nor shall it be deemed incorporated by reference in
any filing under the Securities Act of 1933 or the Exchange Act,
except as shall be expressly set forth by specific reference in
such a filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit Number Title
99.1 Press release of Harvard Bioscience, Inc. issued on April 27,
2017.


About HARVARD BIOSCIENCE, INC. (NASDAQ:HBIO)

Harvard Bioscience, Inc. is a developer, manufacturer and marketer of a range of scientific instruments, systems and lab consumables used for basic research, drug discovery, clinical and environmental testing. The Company’s products are sold to thousands of researchers in over 100 countries through its global sales organization, Websites, catalogs and through distributors. The Company’s product range is organized into three commercial product families: Cell and Animal Physiology (CAP), Lab Products and Services (LPS), and Molecular Separation and Analysis (MSA). The Company sells these products under brand names, including Harvard Apparatus, KD Scientific, Denville Scientific, AHN, Hoefer, Biochrom, BTX, Warner Instruments, MCS, HEKA, Hugo Sachs Elektronik, Panlab, Coulbourn Instruments, TBSI and CMA Microdialysis. The Company’s products consist of instruments, consumables and systems that are made up of various individual products.

HARVARD BIOSCIENCE, INC. (NASDAQ:HBIO) Recent Trading Information

HARVARD BIOSCIENCE, INC. (NASDAQ:HBIO) closed its last trading session 00.00 at 2.40 with 49,554 shares trading hands.

An ad to help with our costs